SAR-102779

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSAR-102779
Drug Alias NameSAR-102779SAR-10279
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 2 receptor antagonists
TargetsNeurokinin 2 receptor
Therapy Area/IndicationsDepressive Disorder, MajorIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A